1.Mechanisms of Core Compound Formula and Compatibility of Traditional Chinese Medicine Components for Prevention and Treatment of Chronic Atrophic Gastritis Based on Huazhuo Jiedu Therapy
Fan GAO ; Xiaoxuan MO ; Fengyue XU ; Jiaye TIAN ; Xinmeng ZHAO ; Jianming JIANG ; Qiuhong GUO
Chinese Journal of Experimental Traditional Medical Formulae 2026;32(21):51-64
ObjectiveTo reveal the compatibility rules of the core compound formula and traditional Chinese medicine (TCM) components for prevention and treatment of chronic atrophic gastritis (CAG) by Huazhuo Jiedu (turbidity-resolving and detoxifying) therapy through uniform design in view of the potential regulatory pathway of endogenous turbid-toxin retention in CAG, elucidate the potential pathway by which the compound formulas regulate the Wnt/β-catenin-connexin 43 (CX43) signaling axis, demonstrated the efficacy enhancement and toxicity attenuation among the components, thus providing experimental evidence for the scientific application of multi-component, multi-target compatibility in TCM compound formulas. MethodsA mouse model of CAG was established with N-methyl-N-nitrosourea (MNU). Sixty mice were randomly allocated into 5 groups (n=12 per group): blank control, model, low-dose Huazhuo Jiedu core compound formula (HXFF-L, 4.004 g·kg-1), high-dose Huazhuo Jiedu core compound formula (HXFF-H, 8.008 g·kg-1), and positive control (folic acid at 11 mg·kg-1 + vitamin B12 at 14 mg·kg-1). The therapeutic efficacy and molecular mechanism of the core compound formula were evaluated by hematoxylin-eosin (HE) staining, Alcian blue-periodic acid-Schiff (AB-PAS) staining, enzyme-linked immunosorbent assay (ELISA), transmission electron microscopy (TEM), immunofluorescence assay, and Western blot. The chemical components of the core compound formula were detected and effective components were screened by ultra-high performance liquid chromatography coupled with quadrupole-orbitrap high-resolution mass spectrometry (UHPLC-Q-Orbitrap HRMS). Another 120 mice were randomized into blank control, model, and 8 HXFF component-combination groups with different dosages (uniform design groups 1-8, n=12 per group). A uniform design was adopted, with pathological scores of mouse gastric tissue as well as serum levels of pepsinogen Ⅰ (PGⅠ), pepsinogen Ⅱ (PGⅡ), and gastrin 17 (GAS17) set as dependent variables. Multivariate linear regression analysis was performed to predict the optimal proportion of core components in the compound formula and explore its compatibility rules. ResultsPharmacodynamic validation showed that compared with the blank control group, the model group had decreased gastric weight index (P<0.01) and increased pathological damage score and inflammatory factor levels (P<0.01). Compared with the model group, these indicators were reversed in the HXFF-L, HXFF-H, and positive control groups (P<0.05, P<0.01). Immunofluorescence results showed that CX43 expression was downregulated in the model group compared with the blank control group (P<0.01) and upregulated in the HXFF-H and positive control groups compared with the model group (P<0.05, P<0.01). Western blot results showed that compared with the blank control group, the model group demonstrated upregulated protein levels of Wnt and β-catenin in the gastric tissue (P<0.01). Compared with those in the model group, the protein level of Wnt was downregulated in the HXFF-L, HXFF-H, and positive control groups (P<0.05, P<0.01), while that of β-catenin was downregulated only in the HXFF-H group (P<0.05). A total of 25 compounds were identified in the core compound formula, including 9 from Coptidis Rhizoma, 10 from Pogostemonis Herba, 2 from Scorpio, and 4 from Lilii Bulbus. According to the category and origin of compounds, Coptidis Rhizoma alkaloids, Pogostemonis Herba volatile oils, Scorpio peptides, and Lilii Bulbus alkaloids were finally selected for component research. The predicted optimal combination of TCM components was as follows: Coptidis Rhizoma alkaloids at 75 mg·kg-1, Pogostemonis Herba volatile oils at 2.25 mg·kg-1, Scorpio protein extract at 90 mg·kg-1, and Lilii Bulbus alkaloids at 9 mg·kg-1. Coptidis Rhizoma alkaloids, Scorpio protein extract, Pogostemonis Herba volatile oils, and Lilii Bulbus alkaloids can ameliorate pathological lesions of the gastric tissue. Scorpio protein extract exerted positive regulatory effects on the gastric function, while Pogostemonis Herba volatile oils and Lilii Bulbus alkaloids showed negative correlations with partial gastric function indicators. Further investigations are required to clarify their dose-effect relationships and safety profiles. ConclusionThis study, for the first time, predicts the optimal proportion and synergistic regulatory mechanism of the core compound formula of Huazhuo Jiedu therapy, revealing the synergistic compatibility logic of its components. It provides a novel strategy for the precise TCM treatment of CAG and the modern development of compound formulas.
2.Mechanisms of Core Compound Formula and Compatibility of Traditional Chinese Medicine Components for Prevention and Treatment of Chronic Atrophic Gastritis Based on Huazhuo Jiedu Therapy
Fan GAO ; Xiaoxuan MO ; Fengyue XU ; Jiaye TIAN ; Xinmeng ZHAO ; Jianming JIANG ; Qiuhong GUO
Chinese Journal of Experimental Traditional Medical Formulae 2026;32(21):51-64
ObjectiveTo reveal the compatibility rules of the core compound formula and traditional Chinese medicine (TCM) components for prevention and treatment of chronic atrophic gastritis (CAG) by Huazhuo Jiedu (turbidity-resolving and detoxifying) therapy through uniform design in view of the potential regulatory pathway of endogenous turbid-toxin retention in CAG, elucidate the potential pathway by which the compound formulas regulate the Wnt/β-catenin-connexin 43 (CX43) signaling axis, demonstrated the efficacy enhancement and toxicity attenuation among the components, thus providing experimental evidence for the scientific application of multi-component, multi-target compatibility in TCM compound formulas. MethodsA mouse model of CAG was established with N-methyl-N-nitrosourea (MNU). Sixty mice were randomly allocated into 5 groups (n=12 per group): blank control, model, low-dose Huazhuo Jiedu core compound formula (HXFF-L, 4.004 g·kg-1), high-dose Huazhuo Jiedu core compound formula (HXFF-H, 8.008 g·kg-1), and positive control (folic acid at 11 mg·kg-1 + vitamin B12 at 14 mg·kg-1). The therapeutic efficacy and molecular mechanism of the core compound formula were evaluated by hematoxylin-eosin (HE) staining, Alcian blue-periodic acid-Schiff (AB-PAS) staining, enzyme-linked immunosorbent assay (ELISA), transmission electron microscopy (TEM), immunofluorescence assay, and Western blot. The chemical components of the core compound formula were detected and effective components were screened by ultra-high performance liquid chromatography coupled with quadrupole-orbitrap high-resolution mass spectrometry (UHPLC-Q-Orbitrap HRMS). Another 120 mice were randomized into blank control, model, and 8 HXFF component-combination groups with different dosages (uniform design groups 1-8, n=12 per group). A uniform design was adopted, with pathological scores of mouse gastric tissue as well as serum levels of pepsinogen Ⅰ (PGⅠ), pepsinogen Ⅱ (PGⅡ), and gastrin 17 (GAS17) set as dependent variables. Multivariate linear regression analysis was performed to predict the optimal proportion of core components in the compound formula and explore its compatibility rules. ResultsPharmacodynamic validation showed that compared with the blank control group, the model group had decreased gastric weight index (P<0.01) and increased pathological damage score and inflammatory factor levels (P<0.01). Compared with the model group, these indicators were reversed in the HXFF-L, HXFF-H, and positive control groups (P<0.05, P<0.01). Immunofluorescence results showed that CX43 expression was downregulated in the model group compared with the blank control group (P<0.01) and upregulated in the HXFF-H and positive control groups compared with the model group (P<0.05, P<0.01). Western blot results showed that compared with the blank control group, the model group demonstrated upregulated protein levels of Wnt and β-catenin in the gastric tissue (P<0.01). Compared with those in the model group, the protein level of Wnt was downregulated in the HXFF-L, HXFF-H, and positive control groups (P<0.05, P<0.01), while that of β-catenin was downregulated only in the HXFF-H group (P<0.05). A total of 25 compounds were identified in the core compound formula, including 9 from Coptidis Rhizoma, 10 from Pogostemonis Herba, 2 from Scorpio, and 4 from Lilii Bulbus. According to the category and origin of compounds, Coptidis Rhizoma alkaloids, Pogostemonis Herba volatile oils, Scorpio peptides, and Lilii Bulbus alkaloids were finally selected for component research. The predicted optimal combination of TCM components was as follows: Coptidis Rhizoma alkaloids at 75 mg·kg-1, Pogostemonis Herba volatile oils at 2.25 mg·kg-1, Scorpio protein extract at 90 mg·kg-1, and Lilii Bulbus alkaloids at 9 mg·kg-1. Coptidis Rhizoma alkaloids, Scorpio protein extract, Pogostemonis Herba volatile oils, and Lilii Bulbus alkaloids can ameliorate pathological lesions of the gastric tissue. Scorpio protein extract exerted positive regulatory effects on the gastric function, while Pogostemonis Herba volatile oils and Lilii Bulbus alkaloids showed negative correlations with partial gastric function indicators. Further investigations are required to clarify their dose-effect relationships and safety profiles. ConclusionThis study, for the first time, predicts the optimal proportion and synergistic regulatory mechanism of the core compound formula of Huazhuo Jiedu therapy, revealing the synergistic compatibility logic of its components. It provides a novel strategy for the precise TCM treatment of CAG and the modern development of compound formulas.
3.Exploring the radiation protection awareness of pediatric CT chaperones and the guidance effects under different scenario modes
Qixiu ZHU ; Jianming LI ; Jinsheng TIAN ; Wangchun DAI ; Siyin ZHOU
Chinese Journal of Radiological Medicine and Protection 2025;45(5):454-459
Objective:To explore the radiation protection awareness of pediatric CT chaperones and the guidance effects under different scenario modes.Methods:This study investigated 491 pediatric CT chaperones aged 24 to 63 who were treated in the Guangzhou Women and Children′s Medical Center from October 2023 to January 2024. These pediatric CT chaperones were guided to wear lead protective equipment, including a lead apron, neck shield, and cap, in the order of the self-pickup mode, single voice-sign language prompt mode, and multiple voice-sign language prompt mode. They were assigned 0.5 to 3 points/piece for each wearing, and their scoring result under different guidance modes were recorded. Moreover, the relationship of the scoring result with the age, gender, education, residence, and accompanying frequency was statistically analyzed.Results:In the self-pickup mode, the wearing accuracy rates of three kinds of protective equipment decreased in the order of the lead apron (31.57%, 155/491), lead cap (23.01%, 113/491), and lead neck shield (16.29%, 80/491). The number of pediatric CT chaperones wearing three kinds of protective equipment properly in the self-pickup mode represented 15.48% (76/491), including two first-time chaperones (2.63%, 2/76) and 74 chaperones experiencing two or more accompanying examinations (97.37%, 74/76). In the single prompt mode, the wearing accuracy rates of three kinds of protective equipment decreased in the order of the lead cap (71.89%, 353/491), lead apron (65.99%, 324/491), and lead neck shield (60.08%, 295/491). The proportion of accurate wearing of three kinds of protective equipment in the single prompt mode was 45.82% (225/491). In the multi-prompt mode, the wearing accuracy rates of three kinds of protective equipment decreased in the order of the lead neck shield (23.63%, 116/491), lead cap (5.09%, 25/491), and lead apron (2.44%, 12/491). Among all the pediatric CT chaperones, 38.70% (190/491) completed the accurate wearing of the three kinds of protective equipment until the multi-prompt mode.Conclusions:Pediatric CT chaperones typically show poor radiation protection awareness, necessitating the guidance of standardized voice-sign language prompts.
4.Identification of high-risk areas for local tumor progression following microwave ablation of colorectal cancer liver metastases using three-dimensional MRI imaging
Lu LI ; Jianming LI ; Hefei LI ; Wenqi CHEN ; Jie HU ; Zhen WANG ; Xueqin TIAN ; Jie YU ; Ping LIANG
Chinese Journal of Ultrasonography 2025;34(5):431-438
Objective:To investigate the spatial distribution patterns of local tumor progression(LTP)after microwave ablation(MWA)for colorectal liver metastases(CRLMs)and identify high-risk progression zones.Methods:A total of 471 CRLM lesions from 246 patients treated with MWA at the Chinese PLA General Hospital between September 2009 and March 2022 were retrospectively analyzed. Three-dimensional visualized MRI image fusion technology was employed to evaluate the spatial relationship between ablation margins(AM)and LTP. The liver was partitioned into nine specific anatomical regions. Machine learning(Boruta algorithm)was used to assess the importance of these regions on LTP risk. Multivariate analysis of LTP was performed at the tumor level and at the patient level using the Cox mixed effects model and the Cox regression model,respectively.Results:LTP occurred in 115 lesions,with an LTP rate of 40.0%(80/200)in ablated lesions which were located in the high-risk progression area,and 12.9%(35/271)in low-risk progression area. Multivariate analysis identified AM < 5 mm,tumor size ≥3 cm and location in high-risk zones as independent risk factors for LTP. Notably,LTP in high-risk zones predominantly clustered around the ablation needle tip.Conclusions:Post-MWA LTP in CRLMs exhibits distinct spatial clustering,particularly at the needle tip within high-risk progression zones. These findings provide critical insights for optimizing ablation strategies and improving clinical outcomes.
5.Tubeless subxiphoid uniportal video-assisted thoracoscopic surgery with percutaneous suspension technique via balance-shaped sternal elevation device in anterior mediastinal masses
Junmin ZHU ; Junjie WANG ; Jianming YUE ; Yixin SUN ; Yichen LIU ; Lei WANG ; Lin LIN ; Jie LI ; Jinlan ZHAO ; Xuehua TU ; Ningying DING ; Jianrong HU ; Chunmei HE ; Leilei TIAN ; Hongtao TANG ; Jiasheng ZHAO ; Cheng CHEN ; Yongxiang SONG ; Yunwei TIAN ; Yong XIAO ; Kaidi LI ; Lin MA ; Yun WANG ; Longqi CHEN ; Dong TIAN
Chinese Journal of Clinical Thoracic and Cardiovascular Surgery 2025;32(11):1603-1609
Objective To assess the clinical value of a novel surgical technique—Tubeless subxiphoid uniportal video-assisted thoracoscopic surgery with percutaneous suspension technique via balance-shaped sternal elevation device in the resection of anterior mediastinal masses. Methods Patients who underwent tubeless subxiphoid uniportal video-assisted thoracoscopic surgery via balance-shaped sternal elevation device in anterior mediastinal masses process at the Department of Thoracic Surgery, West China Hospital, Sichuan University from March to April 2025 were included, and their clinical data were analyzed. Results A total of 4 patients were included, with 2 males and 2 females, aged 58-75 years. The diameter of the tumor was 2.5-3.0 cm. The operation time was 60.0-150.0 min, intraoperative blood loss was 5-10 mL, pain score on the 3rd day after surgery was 0 points, and postoperative hospital stay was 2-3 days. All patients achieved complete resection of the masses and thymus without perioperative complications. Conclusion The tubeless subxiphoid uniportal video-assisted thoracoscopic surgery with percutaneous suspension technique via balance-shaped sternal elevation device technique optimizes surgical visualization and instrument maneuverability while avoiding complications related to conventional anesthesia and tubing, thereby markedly enhancing the minimally invasive profile of anterior mediastinal masses resections. In addition to maintaining procedural safety, this approach effectively reduces postoperative pain and accelerates patient recovery, highlighting its potential for widespread clinical adoption.
6.Exploring the radiation protection awareness of pediatric CT chaperones and the guidance effects under different scenario modes
Qixiu ZHU ; Jianming LI ; Jinsheng TIAN ; Wangchun DAI ; Siyin ZHOU
Chinese Journal of Radiological Medicine and Protection 2025;45(5):454-459
Objective:To explore the radiation protection awareness of pediatric CT chaperones and the guidance effects under different scenario modes.Methods:This study investigated 491 pediatric CT chaperones aged 24 to 63 who were treated in the Guangzhou Women and Children′s Medical Center from October 2023 to January 2024. These pediatric CT chaperones were guided to wear lead protective equipment, including a lead apron, neck shield, and cap, in the order of the self-pickup mode, single voice-sign language prompt mode, and multiple voice-sign language prompt mode. They were assigned 0.5 to 3 points/piece for each wearing, and their scoring result under different guidance modes were recorded. Moreover, the relationship of the scoring result with the age, gender, education, residence, and accompanying frequency was statistically analyzed.Results:In the self-pickup mode, the wearing accuracy rates of three kinds of protective equipment decreased in the order of the lead apron (31.57%, 155/491), lead cap (23.01%, 113/491), and lead neck shield (16.29%, 80/491). The number of pediatric CT chaperones wearing three kinds of protective equipment properly in the self-pickup mode represented 15.48% (76/491), including two first-time chaperones (2.63%, 2/76) and 74 chaperones experiencing two or more accompanying examinations (97.37%, 74/76). In the single prompt mode, the wearing accuracy rates of three kinds of protective equipment decreased in the order of the lead cap (71.89%, 353/491), lead apron (65.99%, 324/491), and lead neck shield (60.08%, 295/491). The proportion of accurate wearing of three kinds of protective equipment in the single prompt mode was 45.82% (225/491). In the multi-prompt mode, the wearing accuracy rates of three kinds of protective equipment decreased in the order of the lead neck shield (23.63%, 116/491), lead cap (5.09%, 25/491), and lead apron (2.44%, 12/491). Among all the pediatric CT chaperones, 38.70% (190/491) completed the accurate wearing of the three kinds of protective equipment until the multi-prompt mode.Conclusions:Pediatric CT chaperones typically show poor radiation protection awareness, necessitating the guidance of standardized voice-sign language prompts.
7.Effects of T2-FLAIR sequence under different imaging conditions on the appearance of ivy sign in patients with moyamoya disease
Wenxue TIAN ; Shen GAO ; Xiangyun RONG ; Zhaoxue ZHANG ; Jianming CAI ; Fugeng SHENG ; Hongtao ZHANG
Military Medical Sciences 2025;49(4):303-306
Objective To investigate the effect of T2-fluid attenuated inversion recovery(T2-FLAIR)sequence on the appearance of ivy sign in patients with moyamoya disease under different imaging conditions.Methods Coronal T2-FLAIR scans were performed in 51 consecutive adult patients with moyamoya disease who had not undergone surgery and had their first visit to this hospital between March and July of 2024.According to the scanning conditions,the patients were divided into 19 and 14 of the echo train length in two groups,and 103,144,and 195 ms of the time of echo(TE)in three groups,respectively.The left and right cerebral hemispheres and whole brains were scored according to the cerebral vascular anatomy,and scores of the ivy sign of left and right cerebral hemispheres and whole brain were compared.Results There was no statistical significance in the ivy sign scores of right and left cerebral hemispheres and whole brain between the two groups with 19 and 14 of the echo train length(P>0.05).Comparison of ivy sign scores in right and left cerebral hemispheres and whole brain was statistically significant among the three groups of TE at 144,103 and 195 ms(P<0.05).Conclusion The best appearance of ivy sign in patients with moyamoya disease is seen under the condition of TE at 195 ms,so appropriately extending the TE time is helpful for ivy sign display.
8.Identification of high-risk areas for local tumor progression following microwave ablation of colorectal cancer liver metastases using three-dimensional MRI imaging
Lu LI ; Jianming LI ; Hefei LI ; Wenqi CHEN ; Jie HU ; Zhen WANG ; Xueqin TIAN ; Jie YU ; Ping LIANG
Chinese Journal of Ultrasonography 2025;34(5):431-438
Objective:To investigate the spatial distribution patterns of local tumor progression(LTP)after microwave ablation(MWA)for colorectal liver metastases(CRLMs)and identify high-risk progression zones.Methods:A total of 471 CRLM lesions from 246 patients treated with MWA at the Chinese PLA General Hospital between September 2009 and March 2022 were retrospectively analyzed. Three-dimensional visualized MRI image fusion technology was employed to evaluate the spatial relationship between ablation margins(AM)and LTP. The liver was partitioned into nine specific anatomical regions. Machine learning(Boruta algorithm)was used to assess the importance of these regions on LTP risk. Multivariate analysis of LTP was performed at the tumor level and at the patient level using the Cox mixed effects model and the Cox regression model,respectively.Results:LTP occurred in 115 lesions,with an LTP rate of 40.0%(80/200)in ablated lesions which were located in the high-risk progression area,and 12.9%(35/271)in low-risk progression area. Multivariate analysis identified AM < 5 mm,tumor size ≥3 cm and location in high-risk zones as independent risk factors for LTP. Notably,LTP in high-risk zones predominantly clustered around the ablation needle tip.Conclusions:Post-MWA LTP in CRLMs exhibits distinct spatial clustering,particularly at the needle tip within high-risk progression zones. These findings provide critical insights for optimizing ablation strategies and improving clinical outcomes.
9.Expert consensus on clinical application of 177Lu-prostate specific membrane antigen radio-ligand therapy in prostate cancer
Guobing LIU ; Weihai ZHUO ; Yushen GU ; Zhi YANG ; Yue CHEN ; Wei FAN ; Jianming GUO ; Jian TAN ; Xiaohua ZHU ; Li HUO ; Xiaoli LAN ; Biao LI ; Weibing MIAO ; Shaoli SONG ; Hao XU ; Rong TIAN ; Quanyong LUO ; Feng WANG ; Xuemei WANG ; Aimin YANG ; Dong DAI ; Zhiyong DENG ; Jinhua ZHAO ; Xiaoliang CHEN ; Yan FAN ; Zairong GAO ; Xingmin HAN ; Ningyi JIANG ; Anren KUANG ; Yansong LIN ; Fugeng LIU ; Cen LOU ; Xinhui SU ; Lijun TANG ; Hui WANG ; Xinlu WANG ; Fuzhou YANG ; Hui YANG ; Xinming ZHAO ; Bo YANG ; Xiaodong HUANG ; Jiliang CHEN ; Sijin LI ; Jing WANG ; Yaming LI ; Hongcheng SHI
Chinese Journal of Clinical Medicine 2024;31(5):844-850,封3
177Lu-prostate specific membrane antigen(PSMA)radio-ligand therapy has been approved abroad for advanced prostate cancer and has been in several clinical trials in China.Based on domestic clinical practice and experimental data and referred to international experience and viewpoints,the expert group forms a consensus on the clinical application of 177Lu-PSMA radio-ligand therapy in prostate cancer to guide clinical practice.

Result Analysis
Print
Save
E-mail